Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
PALO ALTO, Calif., Sept. 3 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that company management will present a corporate overview at two upcoming investor conferences.
Robert M. Myers, President of Jazz Pharmaceuticals, will speak at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 3:15 p.m. EDT at the Palace Hotel in New York City.
Bruce C. Cozadd, Chairman and CEO of Jazz Pharmaceuticals, will speak at the NewsMakers in the Biotech Industry Conference on Wednesday, September 16, 2009 at 9:00 a.m. EDT, at the Millennium Broadway Hotel in New York City.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
You May Also Like